Optometry360 Logo White
  • Conferences
  • Videos
  • Podcasts
  • Quizzes
  • About
    • About Us – Mission
    • Content Awards
    • Media Partners
    • Business Team
    • Brand Ambassadors
    • Industry Council
    • Advisory Board

What are you looking for?

  • Anterior Segment
  • Cataract
  • Cornea and External Disease
  • Diabetic Macular Edema
  • Dry Eye
  • Early Onset Cataracts
  • Exclusives
  • General
  • Geographic Atrophy
  • Glaucoma
  • Industry News
  • Inherited Retinal Disease
  • IOLs
  • Neurotrophic Keratitis
  • Ocular Surface Disease
  • Oculoplastics
  • Optometry
  • Pediatrics
  • Practice Management
  • Presbyopia
  • Refractive Surgery/Vision Correction
  • Residents & Young Ophthalmologists
  • Retina
  • Retina Care 360
  • Retinopathy of Prematurity
  • Spotlight Series
  • The Interventional Glaucoma Project
  • The Ophthalmic Project
  • Trending Topics
Spotlight - The Future of Cryopreserved Amniotic Membrane in Oculoplastic Surgery
Optometry360 Logo White
  • Conferences
  • Videos
  • Podcasts
  • Quizzes
  • About
    • About Us – Mission
    • Content Awards
    • Media Partners
    • Business Team
    • Brand Ambassadors
    • Industry Council
    • Advisory Board
Home > Industry News > Getting Insurers’ Attention About Corneal Cross-Linking
  • General

Getting Insurers’ Attention About Corneal Cross-Linking

Ophthalmology 360
Article Image

Corneal cross-linking (CXL) allow surgeons to improve quality of life for patients with keratoconus, post-LASIK ectasia, and other degenerative corneal disorders, according to a recent article. CXL can also reduce costs for insurers as it allows patients to forgo corneal transplant.

Ophthalmologists must be vocal about the lack of insurance coverage for CXL, presenting data showing its benefits, the article’s author notes. Currently, at least one payer in more than 35 states will cover CXL, but coverage needs to expand so the procedure can be offered to younger patients who likely have limited resources. 

You can read more here. 

Jedlicka J. Next steps for CXL. Cataract & Refractive Surgery Today. July, 2018.  

https://crstoday.com/articles/july-2018/next-steps-for-cxl/. 

Share

Related Content

  • General

Preserflo associated with fewer complications than Xen63 in glaucoma surgery

  • General

Glaucoma may signal complications in intraocular cancers, review suggests

  • General

XEN63 Gel Stent shows sustained glaucoma control over 3 years

  • General

Triple-layer decellularized amniotic membrane linked to low recurrence and minimal complications

  • General

Best of 2025: Imaging advances and therapeutic progress across ophthalmology

  • Cataract

It has never been a better time to be a cataract surgeon: trends and advancements in cataract and refractive surgery

34 Mins Watch

Share

Editor's Picks

  • Neurotrophic Keratitis

Topical insulin shows real-world benefit in neurotrophic keratopathy

  • Retina

GLP-1 RAs have protective effects against AMD

  • Retina

Four-month injection intervals appear safe for long-term stable nAMD

Advisory Board

Saad Ahmad, MD

Ahmad A. Aref, MD, MBA

Roomasa Channa, MD

David Chow, MD, FRCS(C)

Sally L. Baxter, MD, MSc

Neel R. Desai, MD

Nadia Haqqie, MD

Simon Fung, MD, FRCOphth

Sumit Garg, MD

Ross Lakhanpal, MD, FACS

Sanjai Jalaj, MD

Anton Kolomeyer, MD, PhD

Shan Lin, MD

Steven R. Sarkisian, Jr., MD

See All
Optometry360 Logo

Ophthalmology 360® is a dynamic digital platform dedicated to advancing the field of eye care.

Get to Know Us

  • Home
  • About Us
  • Media Partners
  • Advertising Policy
  • Our Advisory Board

Sign up for our Newsletter

Sign up for our Newsletter to get our newest articles instantly!

  • Privacy Policy
  • Advertising Policy
  • Medical Disclaimer
IHM Logo

2026 Ophthalmology 360 is a trademark of International Healthcare Media, LLC. All rights reserved

  • MedJournal360 Icon
  • RareDisease360 Icon
  • MyHero360 Icon
  • Optometry360 Icon
  • Ophtalmology360 Icon